Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | CSF1R | P07333 | 1/20 | 0.39 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KIT | P10721 | 1/20 | 0.39 |
| ▸ | FLT3 | P36888 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.39 |
| ▸ | NUDT1 | P36639 | 2/20 | 0.35 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20864884 | 0.97 | MEN1 (0.36) | MEN1CSF1RPDGFRBMAPTKIT | |
| SCHEMBL20864885 | 0.95 | MEN1 (0.37) | MEN1CSF1RPDGFRBMAPTKIT | |
| SCHEMBL20864883 | 0.94 | MEN1 (0.35) | MEN1CSF1RPDGFRBMAPTKIT | |
| SCHEMBL20864954 | 0.93 | MEN1 (0.36) | MEN1CSF1RPDGFRBMAPTKIT | |
| SCHEMBL20864903 | 0.93 | MAPT (0.34) | MEN1CSF1RPDGFRBMAPTKIT | |
| SCHEMBL20864643 | 0.93 | MEN1 (0.34) | MEN1CSF1RPDGFRBMAPTKIT | |
| SCHEMBL20864892 | 0.91 | MEN1 (0.34) | MEN1CSF1RPDGFRBMAPTKIT | |
| SCHEMBL20864904 | 0.90 | MAPT (0.35) | MEN1CSF1RPDGFRBMAPTKIT | |
| SCHEMBL20864905 | 0.90 | MAPT (0.33) | MEN1CSF1RPDGFRBMAPTKIT | |
| SCHEMBL20864891 | 0.87 | MAPT (0.36) | MEN1CSF1RPDGFRBMAPTKIT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190103560-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | SOULBRAIN CO., LTD. (KR) | 2019-04-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190103560-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | CRY1, CRY2, CYP1A1 | MEN1 495/4885CSF1R 368/4885PDGFRB 3980/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.